Literature DB >> 7710294

Possible etiologic agents for toxic oil syndrome: fatty acid esters of 3-(N-phenylamino)-1,2-propanediol.

R H Hill1, H H Schurz, M Posada de la Paz, I Abaitua Borda, R M Philen, E M Kilbourne, S L Head, S L Bailey, W J Driskell, J R Barr.   

Abstract

The etiologic agent(s) that was responsible for the 1981 toxic oil syndrome [TOS] epidemic in Spain has not been identified. Liquid chromatography combined with atmospheric pressure ionization tandem mass spectrometry was used for the analysis of oils associated with TOS. Analyses focused on measuring 3-(N-phenylamino)-1,2-propanediol [PAP], the 3-oleyl ester of PAP [MEPAP], and the 1,2-di-oleyl ester of PAP [DEPAP]. DEPAP and MEPAP were found more frequently and at higher concentrations in TOS case-associated oils than in control oils with odds ratios of 13.7 (95% CI 5.0-38) and 21.9 (95% 6.1-78), respectively. Other fatty acid esters of PAP are also likely to be present in the TOS case-associated oils. More significantly, DEPAP and MEPAP were found in aniline-denatured rapeseed oil refined at ITH, the oil refining company with the clearest link to TOS cases, yet these PAP esters were not detected in unrefined aniline-denatured samples of rapeseed oil delivered to ITH. These results show that the esters of PAP were products of the ITH refining process and were not formed spontaneously during storage. PAP esters were not detected in samples of other aniline-denatured rapeseed oils that were refined elsewhere, and which were not associated with illness. These findings provide strong support for the hypothesis that one or more of the fatty acid esters of PAP were the etiologic agents for TOS.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7710294     DOI: 10.1007/bf00217625

Source DB:  PubMed          Journal:  Arch Environ Contam Toxicol        ISSN: 0090-4341            Impact factor:   2.804


  16 in total

1.  Chemical correlates of pathogenicity of oils related to the toxic oil syndrome epidemic in Spain.

Authors:  E M Kilbourne; J T Bernert; M Posada de la Paz; R H Hill; I Abaitua Borda; B W Kilbourne; M M Zack
Journal:  Am J Epidemiol       Date:  1988-06       Impact factor: 4.897

2.  Toxic oil syndrome. Current knowledge and future perspectives. Introduction.

Authors:  E C Grandjean
Journal:  WHO Reg Publ Eur Ser       Date:  1992

3.  Bacterial endotoxins.

Authors:  E T Rietschel; H Brade
Journal:  Sci Am       Date:  1992-08       Impact factor: 2.142

4.  In vivo priming of virus-specific cytotoxic T lymphocytes with synthetic lipopeptide vaccine.

Authors:  K Deres; H Schild; K H Wiesmüller; G Jung; H G Rammensee
Journal:  Nature       Date:  1989-11-30       Impact factor: 49.962

Review 5.  Cell-surface anchoring of proteins via glycosyl-phosphatidylinositol structures.

Authors:  M A Ferguson; A F Williams
Journal:  Annu Rev Biochem       Date:  1988       Impact factor: 23.643

6.  New aniline derivatives in cooking oils associated with toxic oil syndrome.

Authors:  A Vázquez Roncero; C Janer del Valle; R Maestro Durán; E Graciani Constante
Journal:  Lancet       Date:  1983-10-29       Impact factor: 79.321

7.  The cutaneous lesions of the Spanish toxic oil syndrome.

Authors:  J L Iglesias; J M De Moragas
Journal:  J Am Acad Dermatol       Date:  1983-07       Impact factor: 11.527

8.  L-tryptophan syndrome: histologic features of scleroderma-like skin changes.

Authors:  S B Guerin; J J Schmidt; J E Kulik; L E Golitz
Journal:  J Cutan Pathol       Date:  1992-06       Impact factor: 1.587

9.  Toxic-oil syndrome: case reports associated with the ITH oil refinery in Sevilla.

Authors:  M Posada; M Castro; E M Kilbourne; F Diaz de Rojas; I Abaitua; J M Tabuenca; A Vioque
Journal:  Food Chem Toxicol       Date:  1987-01       Impact factor: 6.023

Review 10.  Toxic oil syndrome and eosinophilia-myalgia syndrome: May 8-10, 1991, World Health Organization meeting report.

Authors:  R M Philen; M Posada
Journal:  Semin Arthritis Rheum       Date:  1993-10       Impact factor: 5.532

View more
  5 in total

1.  Absorption and effects of 3-(N-phenylamino)-1,2-propanediol esters in relation to toxic oil syndrome.

Authors:  D Closa; E Folch; R E Calaf; J Abián; J Roselló-Catafau; E Gelpí
Journal:  Lipids       Date:  2001-10       Impact factor: 1.880

Review 2.  Innate immunity and inflammation in systemic sclerosis.

Authors:  Robert Lafyatis; Michael York
Journal:  Curr Opin Rheumatol       Date:  2009-11       Impact factor: 5.006

3.  New insights into the mechanisms of innate immune receptor signalling in fibrosis.

Authors:  Robert Lafyatis; Alessandra Farina
Journal:  Open Rheumatol J       Date:  2012-06-15

Review 4.  The Spanish toxic oil syndrome 20 years after its onset: a multidisciplinary review of scientific knowledge.

Authors:  Emilio Gelpí; Manuel Posada de la Paz; Benedetto Terracini; Ignacio Abaitua; Agustín Gómez de la Cámara; Edwin M Kilbourne; Carlos Lahoz; Bénoit Nemery; Rossanne M Philen; Luis Soldevilla; Stanislaw Tarkowski
Journal:  Environ Health Perspect       Date:  2002-05       Impact factor: 9.031

5.  Pharmacogenetic profile of xenobiotic enzyme metabolism in survivors of the Spanish toxic oil syndrome.

Authors:  M G Ladona; M Izquierdo-Martinez; M P Posada de la Paz; R de la Torre; C Ampurdanés; J Segura; E J Sanz
Journal:  Environ Health Perspect       Date:  2001-04       Impact factor: 9.031

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.